wmm, Author at Invivoscribe

About wmm

This author has not yet filled in any details.
So far wmm has created 38 blog entries.

Unlocking the Potential of NGS Clonality and MRD Testing: From Research to High-Throughput Environments – Part 01

wmm2024-07-16T15:02:41-07:00June 25th, 2024|2024 Videos, Featured Videos, Videos|

Leveraging Standardized MRD Assays to Guide CLL Treatment

wmm2024-01-25T10:44:11-08:00January 25th, 2024|2024 Publications, Featured Publications, Publications|

JCA Annual Meeting 2024

wmm2024-02-16T16:12:36-08:00September 19th, 2023|Conferences|

JSLH 2024

wmm2024-02-15T16:54:27-08:00July 20th, 2023|Conferences|

JSH International Symposium 2024

wmm2024-02-15T17:27:38-08:00July 13th, 2023|Conferences|

Japanese Association of Molecular Target Therapy of Cancer 2024

wmm2024-02-16T15:51:45-08:00June 19th, 2023|Conferences|

Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

wmm2023-04-10T20:22:16-07:00March 23rd, 2023|2023 Publications, Featured Publications, Publications|

Minimal/Measurable Residual Disease (MRD) Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor

wmm2023-04-10T20:24:04-07:00March 2nd, 2023|2023 Publications, Featured Publications, Publications|

Comparing Data Generated Using Multiparametric Flow Cytometry, Capillary Electrophoresis, and Next-Generation Sequencing in a Cohort of B-Cell Lymphoproliferative Disorder Samples

wmm2022-12-29T21:22:21-08:00November 15th, 2022|2022 Publications, Featured Publications, Publications|

Development and Implementation of an Automated and Highly Accurate Reporting Process for NGS-based Clonality Testing

wmm2023-01-16T21:30:16-08:00November 2nd, 2022|2022 Videos, 2022 Webinars, Featured Videos, Videos|

High-Throughput Sequencing of TCR Gene Rearrangements as a Useful Tool for Identifying and Tracking Minimal/Measurable Residual Disease (MRD) in Lymphoid Malignancies

wmm2023-01-16T21:27:56-08:00November 2nd, 2022|2022 Videos, 2022 Webinars, Featured Videos, Videos|

NGS-based Clinical Assessment of B- and T-cell Clonality and MRD Determination

wmm2022-10-27T04:25:21-07:00October 26th, 2022|2022 Videos, 2022 Webinars, Featured Videos, Videos|

Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML

wmm2022-10-24T14:57:12-07:00October 24th, 2022|2022 Press Releases, Press Releases|

LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients

wmm2022-12-29T21:19:31-08:00June 4th, 2022|2022 Publications, Featured Publications, Publications|

Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?

wmm2023-01-08T18:20:36-08:00May 30th, 2022|2022 Publications, Featured Publications, Publications|

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine

wmm2022-05-09T17:27:05-07:00May 9th, 2022|2022 Press Releases, Press Releases|

Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients

wmm2022-01-06T05:38:03-08:00January 4th, 2022|2022 Publications, Featured Publications, Publications|

NGS Analysis of Clonality and Minimal Residual Disease in a Patient with Concurrent Richter’s Transformation and CLL/SLL

wmm2022-01-08T23:37:03-08:00December 28th, 2021|2021 Publications, Publications|

Plan for a Successful International Drug Approval with Early Development of the Accompanying CDx

wmm2022-01-04T04:43:02-08:00December 8th, 2021|2021 Publications, Publications|

Machine Learning Algorithms Accelerate Throughput of a Flow – Sequencing Cell Based Assay for an Acute Myeloid Leukemia (AML) Therapeutic Discovery Platform

wmm2022-01-30T21:35:17-08:00November 5th, 2021|2021 Publications, Publications|

Invivoscribe Launches Grant Program to Support Novel Applications for Sequence-Based Analyses of the Immune System

wmm2021-06-24T18:20:34-07:00June 24th, 2021|2021 Press Releases, Press Releases|

Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their Reference Labs in the US, Europe, and China

wmm2021-06-03T20:36:18-07:00June 3rd, 2021|2021 Press Releases, Press Releases|

Feasibility of cell-free DNA collection and clonal immunoglobulin sequencing in South African patients with HIV-associated lymphoma

wmm2023-01-10T16:48:18-08:00April 28th, 2021|2022 Publications, Featured Publications, Publications|

Invivoscribe To Present At Biotech Showcase™ 2019 In San Francisco

wmm2021-02-26T19:10:54-08:00January 3rd, 2019|2019 Press Releases, Press Releases|

Invivoscribe® Releases LymphoTrack® TRB Assay on MiSeq® and LymphoTrack® Minimal Residual Disease (MRD) Software

wmm2021-02-26T19:12:40-08:00November 7th, 2017|2017 Press Releases, Press Releases|